Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-051570
Filing Date
2010-03-10
Accepted
2010-03-09 18:12:45
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1089631
2 LIST OF SUBSIDIIARIES dex211.htm EX-21.1 3402
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1689
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 10324
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10611
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3592
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3619
8 GRAPHIC g66887g52j14.jpg GRAPHIC 42938
  Complete submission text file 0001193125-10-051570.txt   1183645
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 10668261
SIC: 2834 Pharmaceutical Preparations